title: Should active CMV retinitis in non-immunocompromised newborn babies be treated?
authors.forename: F
authors.initials: F
authors.lastname: Barampouti
authors.forename: M
authors.initials: M
authors.lastname: Rajan
authors.forename: W
authors.initials: W
authors.lastname: Aclimandos
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D017726:Cytomegalovirus Retinitis / Q000151:congenital* / Q000188:drug therapy; D005500:Follow-Up Studies; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D007121:Immunocompetence; D007231:Infant, Newborn; D008297:Male
chemical_list: D000998:Antiviral Agents; D015774:Ganciclovir